Biogen Aktie
WKN: 789617 / ISIN: US09062X1037
12.06.2025 07:46:42
|
UCB & Biogen : Phase 3 Trial Of Dapirolizumab Pegol In Systemic Lupus Erythematosus Meets Main Goal
(RTTNews) - UCB (UCB) and Biogen Inc. (BIIB) presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate. In the study, dapirolizumab pegol demonstrated significant clinical improvements in disease activity in people living with moderate-to-severe systemic lupus erythematosus (SLE).
According to the company, dapirolizumab pegol showed consistent improvements in fatigue, a common and debilitating symptom of systemic lupus erythematosus (SLE).
At Week 48, more individuals receiving dapirolizumab pegol experienced no or low disease activity compared to standard of care with differences observed as early as Week 12.
The company noted that the safety profile of dapirolizumab pegol was generally favorable. The safety results were consistent with previous dapirolizumab pegol studies and with that in study participants with systemic lupus erythematosus receiving an immunomodulator.
For More Such Health News, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
03.10.25 |
Minuszeichen in New York: NASDAQ 100 legt schlussendlich den Rückwärtsgang ein (finanzen.at) | |
01.10.25 |
Optimismus in New York: NASDAQ Composite schlussendlich mit Kursplus (finanzen.at) | |
01.10.25 |
Gewinne in New York: S&P 500 präsentiert sich letztendlich fester (finanzen.at) | |
01.10.25 |
Starker Wochentag in New York: NASDAQ 100 präsentiert sich schlussendlich fester (finanzen.at) | |
01.10.25 |
Freundlicher Handel: NASDAQ Composite legt am Mittwochnachmittag zu (finanzen.at) | |
01.10.25 |
Starker Wochentag in New York: S&P 500 bewegt sich am Mittwochnachmittag im Plus (finanzen.at) | |
01.10.25 |
NASDAQ Composite aktuell: NASDAQ Composite mittags mit Zuschlägen (finanzen.at) | |
01.10.25 |
Handel in New York: mittags Pluszeichen im S&P 500 (finanzen.at) |
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Biogen Inc | 136,00 | 3,23% |
|
United Community Banks Inc. | 31,51 | 1,16% |
|